Because it is poorly absorbed after topical application and oral ingestion, bacitracin is considered a low risk to the nursing infant.[1] Only water-miscible cream or gel products should be applied to the breast because ointments may expose the infant to high levels of mineral paraffins via licking.[2] Therefore, an alternate cream product is preferred for application to the breast.
由于局部应用和口服后杆菌肽的吸收较差，因此对哺乳期婴儿的风险较低。[1] 仅应将水溶性乳膏或凝胶产品涂抹于乳房，因为软膏可能会使婴儿通过舔舐接触到高剂量的矿物石蜡。[2] 因此，最好使用替代乳膏产品涂抹于乳房。
